Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. Furthermore, high prevalence of salmonella infection, along with increasing animal healthcare expenditure is also anticipated to assist the market growth during the forecast period.
Key features of the study
• This report provides in-depth analysis of the Global Companion Animal Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global Companion Animal Drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Companion Animal Drugs market
Market Segmentation
• By Product Type
o Antibiotics
o Anti-inflammatory
o Parasiticides
o Ecto-Parasiticides
o Endo-Parasiticides
o Heart worm Products
o Behavioral Products
o Nutritional Products
o Skin care Products
o Vaccines
• By Distribution Channel
o Veterinary Hospitals
o Veterinary Clinics
o Pharmacies and Drug Stores
• By Region
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Argentina
 Mexico
 Rest of Latin America
o Europe
 Germany
 U.K.
 Spain
 France
 Italy
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East & Africa
 GCC Countries
 Israel
 Rest of Middle East & Africa
• Key Players
o Zoetis Inc.
o Merck & Co., Inc.
o Bayer AG
o Eli Lily & Co.
o Sanofi (Merial)
o Ceva Sante Animal
o Virbac Animal Health
o Boehringer Ingelheim GmbH

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snapshot, By Product Type
 Market Snapshot, By Distribution Channel
 Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Companion Animal Drugs Market, By Product Type, 2026 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2026– 2033
 Segment Trends
o Antibiotics
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Anti-inflammatory
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Parasiticides
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Ecto-Parasiticides
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Endo-Parasiticides
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Heart worm Products
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Behavioral Products
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Nutritional Products
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Skin care Products
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Vaccines
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
5. Global Companion Animal Drugs Market, By Distribution Channel, 2026 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2026 – 2033
 Segment Trends
o Veterinary Hospitals
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Veterinary Clinics
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Pharmacies and Drug Stores
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
6. Global Companion Animal Drugs Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, By Region, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, For Regions, 2026–2033
 Regional Trends
o North America
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
 Zoetis Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Merck & Co., Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Bayer AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Eli Lily & Co.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Sanofi (Merial)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Ceva Sante Animal
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Virbac Animal Health
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Boehringer Ingelheim GmbH
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About Us